Percutaneous coronary intervention with second-generation drug-eluting stent versus bare-metal stent: Systematic review and cost-benefit analysis
about
Monocyte-mediated drug delivery systems for the treatment of cardiovascular diseases.Addressing the cost of infractions in the online literature and databases.Healthcare Cost Development in a Type 2 Diabetes Patient Population on Glucose-Lowering Drug Treatment: A Nationwide Observational Study 2006-2014.Cost-effectiveness of everolimus-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: An analysis from the EXAMINATION randomized controlled trialBiodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study
P2860
Percutaneous coronary intervention with second-generation drug-eluting stent versus bare-metal stent: Systematic review and cost-benefit analysis
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Percutaneous coronary interven ...... view and cost-benefit analysis
@ast
Percutaneous coronary interven ...... view and cost-benefit analysis
@en
type
label
Percutaneous coronary interven ...... view and cost-benefit analysis
@ast
Percutaneous coronary interven ...... view and cost-benefit analysis
@en
prefLabel
Percutaneous coronary interven ...... view and cost-benefit analysis
@ast
Percutaneous coronary interven ...... view and cost-benefit analysis
@en
P2093
P2860
P1433
P1476
Percutaneous coronary interven ...... view and cost-benefit analysis
@en
P2093
Jihane Erraji
Kouamé Koffi
Lucien P Coulibaly
P2860
P304
P356
10.1371/JOURNAL.PONE.0177476
P407
P577
2017-05-12T00:00:00Z